Compare TAK & KR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TAK | KR |
|---|---|---|
| Founded | 1781 | 1883 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.3B | 38.9B |
| IPO Year | N/A | 2007 |
| Metric | TAK | KR |
|---|---|---|
| Price | $18.55 | $67.09 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $72.75 |
| AVG Volume (30 Days) | 3.1M | ★ 6.4M |
| Earning Date | 01-01-0001 | 03-04-2026 |
| Dividend Yield | ★ 2.83% | 2.07% |
| EPS Growth | N/A | ★ 23.99 |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $147,123,000,000.00 |
| Revenue This Year | N/A | $3.78 |
| Revenue Next Year | $0.95 | $2.10 |
| P/E Ratio | ★ $41.25 | $293.78 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.99 | $58.60 |
| 52 Week High | $18.79 | $74.90 |
| Indicator | TAK | KR |
|---|---|---|
| Relative Strength Index (RSI) | 76.26 | 54.11 |
| Support Level | $18.20 | $67.44 |
| Resistance Level | $18.79 | $72.20 |
| Average True Range (ATR) | 0.21 | 2.14 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 88.72 | 48.91 |
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
Kroger is one of the largest grocery retailers in the United States with about 2,700 stores across a portfolio of more than 20 supermarket banners. The company boasts an ingrained presence in US communities, citing that it is a top-two grocer in most of its major market areas. Over one fourth of Kroger's roughly $110 billion in nonperishable and fresh food sales (about 75% of revenue) stems from its private-label portfolio, of which the company manufactures about 30% of units via its own food production plants. The company also operates fuel stations and pharmacies at 60% and 80% of its locations, respectively.